30-Year mortality after venous thromboembolism a population-based cohort study

Circulation

Volumn 130, Issue 10, 2014, Pages 829-836

  Søgaard, Kirstine Kobberøe ^a   Schmidt, Morten ^a   Pedersen, Lars ^a   Horváth Puhó, Erzsébet ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Epidemiology; Mortality; Prognosis; Thromboembolism

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; FEMALE; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRIORITY JOURNAL; VENOUS THROMBOEMBOLISM;

EPIDEMIOLOGY; MORTALITY; PROGNOSIS; THROMBOEMBOLISM;

AGED; AGED, 80 AND OVER; COHORT STUDIES; DATABASES AS TOPIC; DENMARK; FEMALE; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; VENOUS THROMBOEMBOLISM;

EID: 84907598990     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.114.009107     Document Type: Article

References (31)

1. Flinterman LE, van Hylckama Vlieg A, Cannegieter SC, Rosendaal FR. Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med. 2012;9:e1001155.
2. Ng AC, Chung T, Yong AS, Wong HS, Chow V, Celermajer DS, Kritharides L. Long-term cardiovascular and noncardiovascular mortality of 1023 patients with confirmed acute pulmonary embolism. Circ Cardiovasc Qual Outcomes. 2011;4:122-128.
3. Reitter SE, Waldhoer T, Mayerhofer M, Eigenbauer E, Ay C, Kyrle PA, Pabinger I. Long-term survival of patients with a history of venous thromboembolism. Ann Hematol. 2011;90:585-594.
4. Klok FA, Zondag W, van Kralingen KW, van Dijk AP, Tamsma JT, Heyning FH, Vliegen HW, Huisman MV. Patient outcomes after acute pulmonary embolism: a pooled survival analysis of different adverse events. Am J Respir Crit Care Med. 2010;181:501-506.
5. Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of survival after deep vein thrombosis and pulmonary embolism: a population-based, cohort study. Arch Intern Med. 1999;159:445-453.
6. Prandoni P, Villalta S, Bagatella P, Rossi L, Marchiori A, Piccioli A, Bernardi E, Girolami B, Simioni P, Girolami A. The clinical course of deep-vein thrombosis.: prospective long-term follow-up of 528 symptomatic patients. Haematologica. 1997;82:423-428.
7. Kniffin WD Jr, Baron JA, Barrett J, Birkmeyer JD, Anderson FA Jr. The epidemiology of diagnosed pulmonary embolism and deep venous thrombosis in the elderly. Arch Intern Med. 1994;154:861-866.
8. Schulman S, Lindmarker P, Holmström M, Lärfars G, Carlsson A, Nicol P, Svensson E, Ljungberg B, Viering S, Nordlander S, Leijd B, Jahed K, Hjorth M, Linder O, Beckman M. Post-thrombotic syndrome, recurrence, and death 10 years after the first episode of venous thromboembolism treated with warfarin for 6 weeks or 6 months. J Thromb Haemost. 2006;4:734-742.
9. Tagalakis V, Patenaude V, Kahn SR, Suissa S. Incidence of and mortality from venous thromboembolism in a real-world population: the Q-VTE Study Cohort. Am J Med. 2013;126:832.e13-832.e21.
10. Prandoni P, Lensing AW, Cogo A, Cuppini S, Villalta S, Carta M, Cattelan AM, Polistena P, Bernardi E, Prins MH. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
11. Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism: the Worcester Venous Thromboembolism Study. Arch Intern Med. 2008;168:425-430.
12. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrøm J. Incidence and mortality of venous thrombosis: a population-based study. J Thromb Haemost. 2007;5:692-699.
13. Andersen TF, Madsen M, Jørgensen J, Mellemkjoer L, Olsen JH. The Danish National Hospital Register: a valuable source of data for modern health sciences. Dan Med Bull. 1999;46:263-268.
14. Helweg-Larsen K. The Danish Register of Causes of Death. Scand J Public Health. 2011;39(suppl):26-29.
15. Schmidt M, Pedersen L, Sørensen HT. The Danish Civil Registration System as a tool in epidemiology [published online ahead of print June 26, 2014]. Eur J Epidemiol. doi: 10.1007/s10654-014-9930-3. Accessed July 2, 2014.
16. Severinsen MT, Kristensen SR, Overvad K, Dethlefsen C, Tjønneland A, Johnsen SP. Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution. J Clin Epidemiol. 2010;63:223-228.
17. Rothman KJ, Greenland S, Lash TL. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008.
18. Glynn RJ, Rosner B. Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism. Am J Epidemiol. 2005;162:975-982.
19. Spencer FA, Goldberg RJ, Lessard D, Reed G, Emery C, Gore JM, Pacifico L, Weitz JI. Factors associated with adverse outcomes in outpatients presenting with pulmonary embolism: the Worcester Venous Thromboembolism Study. Circ Cardiovasc Qual Outcomes. 2010;3:390-394.
20. Ng AC, Chow V, Yong AS, Chung T, Kritharides L. Prognostic impact of the Charlson Comorbidity Index on mortality following acute pulmonary embolism. Respiration. 2013;85:408-416.
21. Tsai J, Grant AM, Soucie JM, Helwig A, Yusuf HR, Boulet SL, Reyes NL, Atrash HK. Clustering patterns of comorbidities associated with in-hospital death in hospitalizations of US adults with venous thromboembolism. Int J Med Sci. 2013;10:1352-1360.
22. Andresen MS, Sandven I, Brunborg C, Njaastad AM, Strekerud F, Abdelnoor M, Smith P, Abildgaard U. Mortality and recurrence after treatment of VTE: long term follow-up of patients with good life-expectancy. Thromb Res. 2011;127:540-546.
23. Spencer FA, Emery C, Joffe SW, Pacifico L, Lessard D, Reed G, Gore JM, Goldberg RJ. Incidence rates, clinical profile, and outcomes of patients with venous thromboembolism: the Worcester VTE study. J Thromb Thrombolysis. 2009;28:401-409.
24. Sørensen HT, Horvath-Puho E, Christensen S, Pedersen L, Prandoni P, Baron JA. Venous thromboembolism and subsequent diagnosis of subarachnoid hemorrhage: a 20-year cohort study. J Thromb Haemost. 2010;8:1710-1715.
25. Sørensen HT, Horvath-Puho E, Pedersen L, Baron JA, Prandoni P. Venous thromboembolism and subsequent hospitalisation due to acute arterial cardiovascular events: a 20-year cohort study. Lancet. 2007;370:1773-1779.
26. Sørensen HT, Mellemkjaer L, Steffensen FH, Olsen JH, Nielsen GL. The risk of a diagnosis of cancer after primary deep venous thrombosis or pulmonary embolism. N Engl J Med. 1998;338:1169-1173.
27. Baron JA, Gridley G, Weiderpass E, Nyrén O, Linet M. Venous thromboembolism and cancer. Lancet. 1998;351:1077-1080.
28. Rothman KJ. Six persistent research misconceptions. J Gen Intern Med. 2014;29:1060-1064.
29. Sørensen HT. Regional administrative health registries as a resource in clinical epidemiology: a study of options, strengths, limitations and data quality provided with examples of use. Int J Risk Saf Med. 1997;10:1-22.
30. Thygesen SK, Christiansen CF, Christensen S, Lash TL, Sørensen HT. The predictive value of ICD-10 diagnostic coding used to assess Charlson Comorbidity Index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11:83.
31. Copeland KT, Checkoway H, McMichael AJ, Holbrook RH. Bias due to misclassification in the estimation of relative risk. Am J Epidemiol. 1977;105:488-495.